All In Biotech

Drug Trial Radar · NCT02783625

Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

A Phase I Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

Last checked: Nov 20, 2026Latest source record: Apr 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

114

Actual

Start

May 23, 2016

Primary completion

Apr 21, 2026

Study completion Apr 21, 2026

Sponsor

Lead sponsor
Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Dana-Farber Cancer Institute; Stanford University
First posted
May 26, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to test the safety of a study drug called duvelisib.

Conditions

  • Lymphoma
  • Relapsed/Refractory T-cell Lymphomas

Interventions

  • RomidepsinDrug

  • BortezomibDrug

  • duvelisibDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. maximum tolerated dose (MTD)Time frame: 1 year

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Stanford University Medical Center

    Stanford, California

  • Dana Farber Cancer Institute

    Boston, Massachusetts

  • University of Washington School of Medicine in St. Louis

    St Louis, Missouri

  • Washington University School of Medicine

    St Louis, Missouri

  • Memorial Sloan Kettering Cancer Center Basking Ridge (Limited protocol activities)

    Basking Ridge, New Jersey

  • Memorial Sloan Kettering Monmouth (Limited protocol activities)

    Middletown, New Jersey

  • Memorial Sloan Kettering Bergen (Limited Protocol Activities)

    Montvale, New Jersey

  • Memorial Sloan Kettering Cancer Center @ Commack (Limitied protocol activities)

    Commack, New York

  • Memorial Sloan Kettering Westchester (Limited protocol activities)

    Harrison, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Memorial Sloan Kettering Nassau (Limited protocol activities)

    Uniondale, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.